drugset / Trial / NCT01374568
Changes in Bone Turnover With Increased Incretin Hormone Exposure
RandomizedParallel-groupDouble-blindHealth-services research
Summary
The purpose of this study is to determine if the use of sitagliptin increases bone formation and reduces bone turnover in postmenopausal women with type 2 diabetes.
Timeline
- Start
- 2010-07
- Primary completion
- 2012-07-06
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sitagliptin | Small molecule | 100 mg | — |